Inflammatory breast cancer appearance at presentation is associated with overall survival

被引:6
|
作者
Balema, Wintana [1 ,2 ,3 ]
Liu, Diane [4 ]
Shen, Yu [4 ]
El-Zein, Randa [5 ]
Debeb, Bisrat G. [1 ,6 ]
Kai, Megumi [2 ,3 ]
Overmoyer, Beth [7 ]
Miller, Kathy D. [8 ]
Le-Petross, Huong T. [2 ,3 ]
Ueno, Naoto T. [1 ,6 ]
Woodward, Wendy A. [1 ,2 ,3 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA
[2] Morgan Welch IBC Clin, Dept Radiat Oncol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Res Program, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Houston Methodist Canc Ctr, Dept Radiol, Houston, TX USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
来源
CANCER MEDICINE | 2021年 / 10卷 / 18期
关键词
breast cancer; breast swelling; erythema; IBC; peau d'orange; redness; skin thickening; T4D; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; CLINICAL MANAGEMENT; DIAGNOSIS; LYMPHANGIOGENESIS; CARCINOMA; CONSENSUS; CENTERS; PROGRAM; BIOLOGY; TIME;
D O I
10.1002/cam4.4170
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Inflammatory breast cancer (IBC) is a clinical diagnosis. Here, we examined the association of a "classic" triad of clinical signs, swollen involved breast, nipple change, and diffuse skin change, with overall survival (OS). Method Breast medical photographs from patients enrolled on a prospective IBC registry were scored by two independent reviewers as classic (triad above), not classic, and difficult to assign. Chi-squared test, Fisher's exact test, and Wilcoxon rank-sum test were used to assess differences between patient groups. Kaplan-Meier estimates and the log-rank test and Cox proportional hazard regression were used to assess the OS. Results We analyzed 245 IBC patients with median age 54 (range 26-81), M0 versus M1 status (157 and 88 patients, respectively). The classic triad was significantly associated with smoking, post-menopausal status, and metastatic disease at presentation (p = 0.002, 0.013, and 0.035, respectively). Ten-year actuarial OS for not classic and difficult to assign were not significantly different and were grouped for further analyses. Ten-year OS was 29.7% among patients with the classic sign triad versus 57.2% for non-classic (p < 0.0001). The multivariate Cox regression model adjusting for clinical staging (p < 0.0001) and TNBC status (<0.0001) demonstrated classic presentation score significantly associated with poorer OS time (HR 2.6, 95% CI 1.7-3.9, p < 0.0001). Conclusions A triad of classic IBC signs independently predicted OS in patients diagnosed with IBC. Further work is warranted to understand the biology related to clinical signs and further extend the understanding of physical examination findings in IBC.
引用
收藏
页码:6261 / 6272
页数:12
相关论文
共 50 条
  • [41] Trends for inflammatory breast cancer: is survival improving?
    Gonzalez-Angulo, A. M.
    Hennessy, B. T.
    Cristofanilli, M.
    Broglio, K.
    Meric-Bernstam, F.
    Giordano, S. H.
    Buchholz, T. A.
    Hortobagyi, G. N.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S266 - S266
  • [42] Trends in treatment and survival of inflammatory breast cancer
    Kilbride, K. E.
    James, A.
    Ashley, P.
    Miltenburg, D. M.
    Shabahang, M. M.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 46 - 46
  • [43] Racial disparities in presentation and survival for lobular breast cancer
    Sandhu, Simran
    Lim, David Wai
    Giannakeas, Vasily
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M. E.
    Yelle, L.
    Lachaine, J.
    VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
  • [45] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M.
    Yelle, L.
    Lachaine, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
  • [46] Effects of young age at presentation on survival in breast cancer
    Nagi S El Saghir
    Muhieddine Seoud
    Mazen K Khalil
    Maya Charafeddine
    Ziad K Salem
    Fady B Geara
    Ali I Shamseddine
    BMC Cancer, 6
  • [47] Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis
    Tamer M. Fouad
    Takahiro Kogawa
    Diane D. Liu
    Yu Shen
    Hiroko Masuda
    Randa El-Zein
    Wendy A. Woodward
    Mariana Chavez-MacGregor
    Ricardo H. Alvarez
    Banu Arun
    Anthony Lucci
    Savitri Krishnamurthy
    Gildy Babiera
    Thomas A. Buchholz
    Vicente Valero
    Naoto T. Ueno
    Breast Cancer Research and Treatment, 2015, 152 : 417 - 417
  • [48] Effects of young age at presentation on survival in breast cancer
    El Saghir, Nagi S.
    Seoud, Muhieddine
    Khalil, Mazen K.
    Charafeddine, Maya
    Salem, Ziad K.
    Geara, Fady B.
    Shamseddine, Ali I.
    BMC CANCER, 2006, 6 (1)
  • [49] Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival
    Siamakpour-Reihani, Sharareh
    Owzar, Kouros
    Jiang, Chen
    Scarbrough, Peter M.
    Craciunescu, Oana I.
    Horton, Janet K.
    Dressman, Holly K.
    Blackwell, Kimberly L.
    Dewhirst, Mark W.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2015, 31 (04) : 386 - 395
  • [50] Triple-Negative Subtype Predicts Poor Overall Survival and High Locoregional Relapse in Inflammatory Breast Cancer
    Li, Jing
    Gonzalez-Angulo, Ana M.
    Allen, Pamela K.
    Yu, Tse K.
    Woodward, Wendy A.
    Ueno, Naoto T.
    Lucci, Anthony
    Krishnamurthy, Savitri
    Gong, Yun
    Bondy, Melissa L.
    Yang, Wei
    Willey, Jie S.
    Cristofanilli, Massimo
    Valero, Vicente
    Buchholz, Thomas A.
    ONCOLOGIST, 2011, 16 (12): : 1675 - 1683